FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995807694> ?p ?o ?g. }

• W1995807694 endingPage "989" @default.
• W1995807694 startingPage "980" @default.
• W1995807694 abstract "Squamous cell lung carcinoma accounts for approximately 30% of all non-small cell lung cancers (NSCLCs). Despite progress in the understanding of the biology of cancer, cytotoxic chemotherapy remains the standard of care for patients with squamous cell lung carcinoma, but the prognosis is generally poor. The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway is one of the most commonly activated signaling pathways in cancer, leading to cell proliferation, survival, and differentiation. It has therefore become a major focus of clinical research. Various alterations in the PI3K/AKT/mTOR pathway have been identified in squamous cell lung carcinoma and a number of agents targeting these alterations are in clinical development for use as single agents and in combination with other targeted and conventional treatments. These include pan-PI3K inhibitors, isoform-specific PI3K inhibitors, AKT inhibitors, mTOR inhibitors, and dual PI3K/mTOR inhibitors. These agents have demonstrated antitumor activity in preclinical models of NSCLC and preliminary clinical evidence is also available for some agents. This review will discuss the role of the PI3K/AKT/mTOR pathway in cancer and how the discovery of genetic alterations in this pathway in patients with squamous cell lung carcinoma can inform the development of targeted therapies for this disease. An overview of ongoing clinical trials investigating PI3K/AKT/mTOR pathway inhibitors in squamous cell lung carcinoma will also be included." @default.
• W1995807694 created "2016-06-24" @default.
• W1995807694 creator A5003887338 @default.
• W1995807694 creator A5050567867 @default.
• W1995807694 creator A5051558249 @default.
• W1995807694 date "2014-09-01" @default.
• W1995807694 modified "2023-10-01" @default.
• W1995807694 title "Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma" @default.
• W1995807694 cites W1969525589 @default.
• W1995807694 cites W1978194521 @default.
• W1995807694 cites W1981711832 @default.
• W1995807694 cites W1983516907 @default.
• W1995807694 cites W1983570871 @default.
• W1995807694 cites W1986814178 @default.
• W1995807694 cites W1989116783 @default.
• W1995807694 cites W1992372579 @default.
• W1995807694 cites W1999213748 @default.
• W1995807694 cites W2000263590 @default.
• W1995807694 cites W2001587810 @default.
• W1995807694 cites W2014080468 @default.
• W1995807694 cites W2015813074 @default.
• W1995807694 cites W2022850278 @default.
• W1995807694 cites W2023241927 @default.
• W1995807694 cites W2026569756 @default.
• W1995807694 cites W2027114592 @default.
• W1995807694 cites W2029754521 @default.
• W1995807694 cites W2033672070 @default.
• W1995807694 cites W2033808368 @default.
• W1995807694 cites W2037385288 @default.
• W1995807694 cites W2050146483 @default.
• W1995807694 cites W2059726806 @default.
• W1995807694 cites W2060629288 @default.
• W1995807694 cites W2062494260 @default.
• W1995807694 cites W2068770010 @default.
• W1995807694 cites W2069489023 @default.
• W1995807694 cites W2070765493 @default.
• W1995807694 cites W2077529224 @default.
• W1995807694 cites W2082303527 @default.
• W1995807694 cites W2088955344 @default.
• W1995807694 cites W2090733433 @default.
• W1995807694 cites W2092259238 @default.
• W1995807694 cites W2100785570 @default.
• W1995807694 cites W2101441514 @default.
• W1995807694 cites W2101982508 @default.
• W1995807694 cites W2102148658 @default.
• W1995807694 cites W2106787323 @default.
• W1995807694 cites W2111065680 @default.
• W1995807694 cites W2112189502 @default.
• W1995807694 cites W2112842133 @default.
• W1995807694 cites W2114553148 @default.
• W1995807694 cites W2114744705 @default.
• W1995807694 cites W2126022920 @default.
• W1995807694 cites W2126783165 @default.
• W1995807694 cites W2129171769 @default.
• W1995807694 cites W2132063042 @default.
• W1995807694 cites W2136950355 @default.
• W1995807694 cites W2137373982 @default.
• W1995807694 cites W2139526755 @default.
• W1995807694 cites W2139810669 @default.
• W1995807694 cites W2142364508 @default.
• W1995807694 cites W2143897224 @default.
• W1995807694 cites W2149218373 @default.
• W1995807694 cites W2150937214 @default.
• W1995807694 cites W2154871907 @default.
• W1995807694 cites W2156728903 @default.
• W1995807694 cites W2158305336 @default.
• W1995807694 cites W2159750196 @default.
• W1995807694 cites W2164895949 @default.
• W1995807694 cites W2165404212 @default.
• W1995807694 cites W2165948908 @default.
• W1995807694 cites W2168485476 @default.
• W1995807694 cites W2169276102 @default.
• W1995807694 cites W2170744484 @default.
• W1995807694 cites W2171293990 @default.
• W1995807694 cites W2275877493 @default.
• W1995807694 cites W2327437619 @default.
• W1995807694 cites W2509319388 @default.
• W1995807694 cites W2531168802 @default.
• W1995807694 cites W2566863750 @default.
• W1995807694 cites W2605097697 @default.
• W1995807694 cites W4251622665 @default.
• W1995807694 doi "https://doi.org/10.1016/j.ctrv.2014.06.006" @default.
• W1995807694 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25037117" @default.
• W1995807694 hasPublicationYear "2014" @default.
• W1995807694 type Work @default.
• W1995807694 sameAs 1995807694 @default.
• W1995807694 citedByCount "91" @default.
• W1995807694 countsByYear W19958076942014 @default.
• W1995807694 countsByYear W19958076942015 @default.
• W1995807694 countsByYear W19958076942016 @default.
• W1995807694 countsByYear W19958076942017 @default.
• W1995807694 countsByYear W19958076942018 @default.
• W1995807694 countsByYear W19958076942019 @default.
• W1995807694 countsByYear W19958076942020 @default.
• W1995807694 countsByYear W19958076942021 @default.
• W1995807694 countsByYear W19958076942022 @default.
• W1995807694 countsByYear W19958076942023 @default.
• W1995807694 crossrefType "journal-article" @default.

• next